Dr. Peter Sandor has 25 years of biopharmaceutical leadership experience and currently serves as the senior vice president, Primary Focus Lead, Primary Focus Immuno-oncology at Astellas.In his role, Dr. Sandor has responsibility for leading the strategic direction of Astellas’ early immuno-oncology research and development pipeline and plays an integral role in the expansion of Astellas’ presence in oncology. Dr. Sandor has previously served as vice president, Head of Marketing Strategy, Oncology at Astellas.Prior to Astellas, he was Head of Global Marketing Oncology at Amgen, held several global leadership positions at Bayer Healthcare, led the global launch of a key oncology compound for Berlex and held multiple marketing roles with Schering AG in Germany and Hungary, respectively. Dr. Sandor began his career in academia as a scientific advisor to the Hungarian Academy of Sciences. He earned his Doctor of Medicine at the University of Pécs, Hungary, his Master of Business Administration from Middlesex University, London and Faculty of Business and Economy, University of Pécs, Hungary, and his Postgraduate Degree in Marketing from the University of Pécs, Hungary.